ArticleMolecular cancer therapeutics2017

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers.

Aaron M Goodman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.